Assenagon Asset Management
ADVM

Assenagon Asset Management’s Adverum Biotechnologies ADVM Stock Holding History

Assenagon Asset Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,413
Closed -$164K – 1313
2024
Q3 		$164K Sell
23,413
-594,497
-96% -$4.32M ﹤0.01% 1338
2024
Q2 		$4.24M Buy
617,910
+259,191
+72% +$2.41M 0.01% 680
2024
Q1 		$5.07M Buy
+358,719
New +$5.46M 0.01% 605
2023
Q2 		– Sell
-84,065
Closed -$603K – 1319
2023
Q1 		$603K Hold
84,065
– – ﹤0.01% 1181
2022
Q4 		$487K Sell
84,065
-10,110
-11% -$76.7K ﹤0.01% 1180
2022
Q3 		$895K Hold
94,175
– – ﹤0.01% 954
2022
Q2 		$1.13M Sell
94,175
-5,098
-5% -$53.4K ﹤0.01% 1038
2022
Q1 		$1.3M Buy
99,273
+55,316
+126% +$809K ﹤0.01% 984
2021
Q4 		$774K Sell
43,957
-102,724
-70% -$2.06M ﹤0.01% 1109
2021
Q3 		$3.18M Sell
146,681
-15,989
-10% -$408K 0.01% 555
2021
Q2 		$5.69M Buy
+162,670
New +$8.76M 0.02% 457
2021
Q1 		– Sell
-2,220
Closed -$241K – 1181
2020
Q4 		$241K Sell
2,220
-25,100
-92% -$3.11M ﹤0.01% 939
2020
Q3 		$2.81M Sell
27,320
-4,702
-15% -$704K 0.02% 498
2020
Q2 		$6.69M Buy
+32,022
New +$5.67M 0.04% 265
2019
Q1 		– Sell
-10,056
Closed -$317K – 922
2018
Q4 		$317K Buy
+10,056
New +$409K ﹤0.01% 913

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Assenagon Asset Management's ADVM Position: Q4 2024 in Review

Assenagon Asset Management sold out of Adverum Biotechnologies (ADVM) in Q4 2024, closing a stake of 23,413 shares — an estimated $164K sold.

Assenagon Asset Management first reported a position in ADVM in Q4 2018 and held it in 15 quarters. The position peaked at $6.69M in Q2 2020. 69 funds tracked by Wall St. Rank hold ADVM as of Q4 2024.

  • Assenagon Asset Management reported no remaining Adverum Biotechnologies position as of Q4 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 23,413 Adverum Biotechnologies shares in Q4 2024, an estimated $164K.
  • Assenagon Asset Management first reported a position in Adverum Biotechnologies in Q4 2018 and held it in 15 quarters.
  • Assenagon Asset Management's Adverum Biotechnologies position peaked at $6.69M in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2024.

Based on Assenagon Asset Management's 13F filing for Q4 2024, filed 14 Jan 2025.